Individuals with advanced lung cancer often have other comorbid conditions, and many may be on complex, costly, and even inappropriate medication regimens. A new British Journal of Clinical…
At the Academy of Medical Sciences, we have a commitment to developing talented researchers. To do this, we have created a range of innovative programmes of tailored support that respond to specific…
Antarctica is the coldest, windiest, highest and driest continent on Earth, yet it is the unexplored nature of its landscape that is the defining characteristic. The Antarctic Treaty which…
We were delighted to be part of the team which formed the Glasgow Pharmacological Society (GPS) in 2016, with funding from the British Pharmacological Society’s Ambassadors scheme. The idea behind…
The exchange of ideas and knowledge is an essential aspect of being a scientist that enhances our collective progress. As academics our contributions to the field, both as individuals and teams, are…
The first objective set out in the Society’s new five-year strategy for 2018-2022, which launched at the end of 2017, is “To remove barriers to participation and success, while welcoming equality and…
Opioid analgesics have been a mainstay of pain treatment for centuries but over the past few decades, their overuse for both medical and non-medical reasons has led to what has been described in the…
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis - or medical marijuana - for helping patients with intractable epilepsy, in which seizures fail…
PhD programs have always been tough. In my postgraduate days, ‘second-year blues’ was rampant: the process seemed to have taken an age already, but there was still such a long haul ahead. What seems…
